4-(5-Ethyl-1,2,4-oxadiazol-3-yl)-2-{[3-(trifluoromethyl)phenyl]methyl}-1H,2H,3H,5H,6H,7H,8H-pyrido[1,2-c]pyrimidine-1,3-dione CAS 1775402-65-7
Purity 97%+In StockPharmaceutical Standards
| CAS No. | 1775402-65-7 |
| Molecular Formula | C20H19F3N4O3 |
| Molecular Weight | 420.39 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
Order 4-(5-Ethyl-1,2,4-oxadiazol-3-yl)-2-{[3-(trifluoromethyl)phenyl]methyl}-1H,2H,3H,5H,6H,7H,8H-pyrido[1,2-c]pyrimidine-1,3-dione (CAS 1775402-65-7) pharmaceutical standards reference standard from CATO: ISO 17034 accredited producer, 130,000+ catalog items in stock. Molecular formula: C20H19F3N4O3. Molecular weight: 420.39 g/mol. COA included with every batch.
Physical & Chemical Properties
| Molecular Formula | C20H19F3N4O3 |
| Molecular Weight | 420.39 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 12.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1994 |
| Halogen Content | F-containing |
| Nitrogen Atoms | 4 |
Related Ethyl Standards
- 4-(5-Ethyl-1,2,4-oxadiazol-3-yl)-2-{[4-(trifluoromethyl)phenyl]methyl}-1H,2H,3H,5H,6H,7H,8H-pyrido[1,2-c]pyrimidine-1,3-dione (CAS 1775553-79-1)
- 4-(5-Ethyl-1,2,4-oxadiazol-3-yl)-2-({4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl}methyl)-1H,2H,3H,5H,6H,7H,8H-pyrido[1,2-c]pyrimidine-1,3-dione (CAS 1775353-81-5)
- 4-(5-Methyl-1,2,4-oxadiazol-3-yl)-2-{[4-(trifluoromethoxy)phenyl]methyl}-1H,2H,3H,5H,6H,7H,8H-pyrido[1,2-c]pyrimidine-1,3-dione (CAS 1775336-77-0)
- 1-((5-Benzyl-1,2,4-oxadiazol-3-yl)methyl)-5-(3-(thiophen-3-yl)-1,2,4-oxadiazol-5-yl)pyridin-2(1H)-one (CAS 1396761-12-8)
- 2-[4-(5-Ethyl-1,2,4-oxadiazol-3-yl)-1,3-dioxo-1H,2H,3H,5H,6H,7H,8H-pyrido[1,2-c]pyrimidin-2-yl]-N-[(4-methylphenyl)methyl]acetamide (CAS 1775308-53-6)
- 2-[4-(5-Methyl-1,2,4-oxadiazol-3-yl)-1,3-dioxo-1H,2H,3H,5H,6H,7H,8H-pyrido[1,2-c]pyrimidin-2-yl]-N-(2,4,6-trimethylphenyl)acetamide (CAS 1775337-05-7)
- 2-[4-(5-Ethyl-1,2,4-oxadiazol-3-yl)-1,3-dioxo-1H,2H,3H,5H,6H,7H,8H-pyrido[1,2-c]pyrimidin-2-yl]-N-(4-ethylphenyl)acetamide (CAS 1775337-70-6)
- 2-[4-(5-Ethyl-1,2,4-oxadiazol-3-yl)-1,3-dioxo-1H,2H,3H,5H,6H,7H,8H,9H-pyrimido[1,6-a]azepin-2-yl]-N-(4-methylphenyl)acetamide (CAS 1775345-65-7)
Recommended Standards
- Dalilesen Impurity 16 (CAS CATO-C4X-301016)
- Regadenoson Impurity 59 (CAS CATO-C4X-198559)
- Ethyl 2-[bis(2-naphthalenyloxy)phosphinyl]acetate (CAS 188945-33-7)
- 1,3-Benzodioxol-4-Ylmethanol (CAS 769-30-2)
- 1-Methoxypent-4-yn-2-ol (CAS 55646-38-3)
- 6-Amino-3-ethyl-1,3,5-triazine-2,4(1H,3H)-dione (CAS 56611-50-8)
- (6-Chloro-1-ethyl-1H-benzo[d]imidazol-2-yl)methanamine (CAS 1285446-33-4)
- 1-(4-(Benzo[d][1,3]dioxol-5-yl)-2,5-dimethylfuran-3-yl)ethanone (CAS 88484-91-7)
- 2,2-Dimethyl-6-nitro-2,3-dihydrobenzofuran-7-ol (CAS 832713-81-2)
- Tripeptide-10 citrulline (CAS 960531-53-7)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 13829788188 / jacky.chen@cato-chem.com